Russian Science Support Foundation

The landscape of genome editing has dramatically changed over the recent five years, and evolved from scientific ideas and laboratory research to multiple clinical applications changing patients' lives, creating new commercial opportunities with substantial investments in the field and notable deals, and societal dilemmas raising many discussion items for the medical community and general public.Today, many of the cutting-edge R&D efforts, investments, regulatory initiatives, and ethical discussions occur in this field.In what way can the market and society keep up with the latest scientific discoveries, and what is the next big thing to come?In this essay, I will discuss the opportunities and challenges of current cell and gene therapy market, recent approvals and their clinical and economic impact, novel technologies that are entering clinical trials, and ethical considerations that some of these technologies and/or their applications provoke.